Bioterrorism Detection Equipment Market to Reach $1.02 Billion by 2012, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Bioterrorism Detection Equipment market. The potential risk of a bioterrorism attack is the primary growth driver of the global bioterrorism detection equipment market. The US represents the single largest market for such equipment, followed by Europe. However, in terms of growth, the Middle East leads with the fastest growth between 2008 and 2015.

San Jose, California (PRWEB), June 24, 2009 -- Over the past few years, the US spending on bioweapons prevention and defense has been growing only modestly, unlike in the early part of this decade when the government allocated significant funds to counter bioterrorism (http://www.strategyr.com/Bioterrorism_Market_Report.asp). This has been projected as the primary factor for the growth of the US bioterrorism detection equipment (http://www.strategyr.com/Bioterrorism_Market_Report.asp) market over the forecast period 2008-2015. The second largest market, trailing with a sizeable difference, is Europe where funding and programs for biodefense (http://www.strategyr.com/Bioterrorism_Market_Report.asp) are not strong enough to provide substantial impetus for market growth.

On the other hand, Asia and the Middle East, though characterized with a small value base, show robust potential for growth. The attractiveness of the Middle East market stems from the volatility of the region and increased governmental interest in acquiring biological agent detection equipment.

The global marketplace is characterized by participants such as Acambis Plc, AVI BioPharma, Inc., Blücher GmbH, Evogen, Inc., Human Genome Sciences Inc., ICX Technologies, Inc., ILC Dover LP, Medarex, Inc., Northrop Grumman Corporation, PharmAthene, Inc., Scott Health & Safety, Smiths Detection, The Baker Company, and Universal Detection Technology. Additional market participants include Advanced Life Sciences Holdings, Inc., ADVNT Biotechnologies, BioFactura, Inc., Coley Pharmaceutical Group, Inc., Crucell, CytoGenix, Emergent BioSolutions, General Dynamics Canada, Gulf Security Solutions, Ibis Biosciences, Inc., Ichor Medical Systems, Innovative Biosensors, Inc., Integrated BioTherapeutics, IR BioSciences Holdings Inc., Kadinuo Science and Technology Company, Medison Pharma Ltd., NanoSensors, Inc., Nanotherapeutics, Inc., Omrix Biopharmaceuticals, Safe Life Corp., Security Solutions International, SRI International, U.S. BioDefense, Inc.

"Bioterrorism: A Global Strategic Business Report" announced by Global Industry Analysts, Inc. provides a comprehensive review of market drivers, product profile, players, competition, recent developments, mergers, acquisitions, and other strategic industry activities. Analysis is presented for major geographic markets such as the United States, Europe, Asia and the Middle East.

For more details about this comprehensive market research report, please visit - http://www.strategyr.com/Bioterrorism_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) (http://www.strategyR.com/) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.

Telephone 408-528-9966

Fax 408-528-9977

Email press@StrategyR.com

Web Site http://www.StrategyR.com/

# # #